OpenAlex
PricingAboutJobs
Log inGet started
Work

Discovery of MLN4924, a Novel, First in Class Nedd8 Activating Enzyme Inhibitor for the Treatment of Cancer

HTML

Year: 2007
Type: article
Source: Molecular Cancer Therapeutics
Authors: Mark Rolfe, Michael A. Milhollen, Allison Berger, Pete Smith, Steven Langston, Teresa A. Soucy
Institution: Takeda Oncology (United States)
Language: English

Topic: Ubiquitin and proteasome pathways
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: MLN4924, NEDD8-activating enzyme inhibitor, ubiquitin-proteasome system, DNA re-replication, apoptosis, DNA damage response, tumor xenografts, anticancer activity, small molecule inhibitors, cancer therapy, bortezomib, multiple myeloma
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2258304092
FWCI: 0.097
Cites:
Cited by: 1
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security